Cleveland BioLabs
is a biopharmaceutical company that develops and commercializes novel immunotherapies for the treatment of cancer... Read moreCleveland BioLabs
is a biopharmaceutical company that develops and commercializes novel immunotherapies for the treatment of cancer... Read more
CEO
Add
News
Jul 29, 2021
Seeking Alpha
Cleveland BioLabs: Cleveland BioLabs secures $90M in debt and equity financing
Jul 28, 2021
BioSpace
Cleveland BioLabs: Cytocom Inc. Announces Completed Merger with Cleveland BioLabs
Jul 28, 2021
BizWest
Cleveland BioLabs: Cytocom closes on merger, begins Nasdaq trading
Jul 09, 2021
BizWest
Cleveland BioLabs: Shareholders approve Cytocom-Cleveland BioPharma merger
Jul 06, 2021
Markets Insider
Cleveland BioLabs: Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger
Jun 18, 2021
Benzinga
Cleveland BioLabs: Registration Statement Related To Cleveland BioLabs-Cytocom Merger Declared Effective By SEC
Apr 14, 2021
Accesswire
Press Release: Cleveland BioLabs : Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532
Feb 23, 2021
FinanzNachrichten
Cleveland BioLabs: Cleveland BioLabs, Inc. Announces Closing of $14 Million Registered Direct Offering of Common Stock
Feb 23, 2021
MarketScreener
Cleveland BioLabs: Cleveland BioLabs : Announces Closing of $14 Million Registered Direct Offering of Common Stock
Feb 19, 2021
BioSpace
Cleveland BioLabs: Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock
Cleveland BioLabs Competitors
1
2
3
4
5
6
7
8
9
10